NCT06363461 - Study of TDM-180935 in Atopic Dermatitis Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 13, 2024

Primary Completion Date

March 8, 2025

Study Completion Date

April 8, 2025

Conditions

Atopic Dermatitis

Interventions

DRUG

TDM-180935 topical ointment 1.0%

DRUG

TDM-180935 topical ointment 2.0%

DRUG

TDM-180935 topical vehicle ointment 1

DRUG

TDM-180935 topical vehicle ointment 2

Trial Locations (7)

Site 2, Norfolk

Site 7, Anderson

Site 4, New Brighton

Site 5, Rolling Meadows

Site 8, Covington

Site 1, College Station

Site 3, Austin

All Listed Sponsors

collaborator

Therapeutics, Inc.

INDUSTRY

lead

Technoderma Medicines Inc.

INDUSTRY